Dr Androulla Eleftheriou, TIF Executive Director, presents the patients’ organisation expectations for the revision of the Blood Directive. These include the legal framework for the establishment of a European supervisory mechanism, common guidelines and training to the competent national bodies, mandatory recording of blood needs, the adoption of specific measures in cases of shortages and the inclusion of new substances of human origin. For more details read the full statement here.